source
- Johnson & Johnson drops two CAR-T lymphoma programs as market competition intensifiesJohnson & Johnson announced it is discontinuing two CAR-T cell therapy programs aimed at treating B-cell lymphoma. The decision comes as the market for lymphoma treatments has become crowded, with…
- Boehringer Ingelheim names Christie Bloomquist as SVP of US corporate affairs and head of its Cares FoundationBoehringer Ingelheim announced that Christie Bloomquist has been appointed senior vice president of corporate affairs for its U.S. human pharmaceutical business. In addition to overseeing corporat…